引用本文: | 周建娅, 周建英. 帕博利珠单抗联合化疗一线治疗晚期非鳞状非小细胞肺癌:KEYNOTE-021研究G队列长期生存数据[J]. 循证医学, 2021, 21(4): 208-213. DOI: 10.12019/j.issn.1671-5144.2021.04.004 |
Citation: | ZHOU Jian-ya, ZHOU Jian-ying. Pembrolizumab With or Without Chemotherapy as First-Line Therapy for Advanced Nonsquamous NSCLC: Comments to Long-Term Overall Survival Data of Cohort G in KEYNOTE-021 Study[J]. Journal of Evidence-Based Medicine, 2021, 21(4): 208-213. DOI: 10.12019/j.issn.1671-5144.2021.04.004 |